A weekly prescription injection with the same active ingredient as Mounjaro® and Zepbound®. By working with FDA-regulated compounding pharmacies, Bioverse can offer this medication in personalized doses to fit your unique needs.
80% of Tirzepatide users report improved health and weight loss results.
Why Bioverse works
Personalized plans tailored to your goals, with ongoing support and dosage adjustments.
How Bioverse works
1
Complete a Quick Medical Intake
Answer a few questions about your health and goals — takes under 7 minutes.
2
Provider evaluation
A medical professional will review your intake and determine what’s right for you.
3
Personalized plan
Receive a customized plan tailored to your body and goals.
4
Continuous Support
Unlimited online access to follow-ups, adjustments, and answers to questions.
Lose weight with prescription Tirzepatide
Start today for just $57/week*
No commitment. Cancel anytime.
Meet Compounded Tirzepatide
How to take
- Compounded GLP-1s are only one injection per week
- If prescribed, a licensed provider will include treatment instructions with your weight loss plan
Potential side effects
- Some common side effects of Compounded Segmaglutide include nausea, diarrhea, and vomiting
- To help your body adjust, a fast-acting anti-nausea medication is included with treatment at no extra cost, if eligible
Personalized Treatment
- If appropriate, a provider will prescribe a GLP-1 injection based on your health history and weight loss goals
- Compounded medications are prescribed by licensed providers and made in certified pharmacies.
- Your dosage and how fast you increase your dosage is personalized to you, and your provider can help make adjustments as needed, anytime
Compounded tirzepatide is not approved by the FDA, and the FDA does not verify its safety, effectiveness, or quality.
All prescription products require an online consultation with a Bioverse licensed healthcare provider, who will determine if a prescription is medically appropriate.
Zepbound® (tirzepatide) and Zepbound® (tirzepatide) are not compounded. Zepbound® is FDA-approved for weight loss; Mounjaro® is FDA-approved for type 2 diabetes but may be prescribed off-label for weight management at a provider’s discretion.
*$57/week is the price for a 6 month supply, typically paid upfront.
Complete your intake in under 7 minutes. No insurance needed.
Tailored weight-loss therapy, compounded for you.
Licensed medical providers
No membership fees
Fast, free shipping
© 2026 BIOVERSE, Inc. All rights reserved.
Personalized Treatment Plans
Affordable GLP-1s
$58/week for a 6-month supply, Bioverse Weight Loss aims to be the most affordable GLP-1 program.
Lose weight in your first month
Lose weight in your first month
Members report losing ~11 lbs in 30 days*
Multi-month plan: Payment is required upfront with a multi-month commitment. Final pricing depends on the chosen product and plan. All data is all through self-reported users. *Individual results vary. Competitive comparison: Price comparison across 12 leading providers (as of December 2024) indicates one of the most cost-effective options for tirzepatide-based weight-loss plans over a 12-month period.
*Bioverse offers compounded drug products, including semaglutide and tirzepatide, which are not FDA-approved. Compounded drug products, including semaglutide and tirzepatide, are not approved or evaluated for safety, effectiveness, or quality by the FDA. These products are compounded in accordance with applicable laws and are to be used only as prescribed by a licensed healthcare provider.
*Any references to active ingredients such as semaglutide and tirzepatide being similar to those in FDA-approved products like Ozempic, Wegovy, Mounjaro, or Zepbound are intended solely to provide information about the active ingredients and are not intended to imply that our compounded products are equivalent to or interchangeable with these FDA-approved products.
*Ozempic® (semaglutide), Wegovy® (semaglutide), Mounjaro® (tirzepatide), and Zepbound® (tirzepatide), and Generic Liraglutide are not compounded. Ozempic®, Mounjaro®, and Generic Liraglutide are FDA-approved for type 2 diabetes treatment but may also be prescribed for weight loss at a healthcare provider’s discretion. Wegovy® and Zepbound® are FDA-approved for weight loss.
Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. Bioverse is not affiliated with or endorsed by Novo Nordisk A/S or Eli Lilly and Company.
Join other members achieving life-changing results.